Skip to main content

Struck by Slight Subversion

Premium

I read your recent editorial and would like to make a few comments, with the cloak of anonymity. I have been working in startup biotech companies for over 10 years. I live in the Bay Area and have a number of friends in the biotech industry. I read a number of different journals, and recently discovered your magazine.

I was immediately struck by the interesting mixture of technological information, business articles, and gossip. It is a good mix. What a refreshing change to read about people speaking openly of layoffs in a trade journal. Other journals tend to ignore or whitewash the cutthroat aspects of the industry, but you don’t and that is what makes your magazine interesting and unique.

You should continue with your open and slightly subversive style, applying it to the biotech industry as a whole. No need to limit yourself to just genomics.

Name withheld

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.